>Beneficiaries in EDs of private equity hospitals experienced 7.0 additional deaths per 10 000 visits after acquisition relative to control (13.4% increase from a raw baseline of 52.4 deaths per 10 000; P = 0.009).

In other words, an increase of 0.00055 deaths per visit.

>Limitation: >Potential unmeasured confounding; lack of generalizability to other acquisitions or patient populations.